What is the study about?
Opill–the first daily birth control pill available without a prescription in the US–became available online and at most major retailers in the spring of 2024. This study will explore the experiences of people who have tried to get Opill, including factors that made it easy or difficult for them to access Opill, number and type of stores visited, the quality of interactions with pharmacy/retail staff, whether they ended up obtaining Opill, and sources of information about Opill.
Who can participate?
In order to be eligible, you must:
- Have tried to obtain Opill for yourself or for someone else, regardless of whether you were able to purchase the product
- Speak English or Spanish
Why participate?
The more we can document your stories–both positive and negative–about seeking or obtaining Opill, the more we can advocate for this information to be part of improving how people access and learn about Opill. Individuals who complete the survey can receive a $20 gift card.
Who is conducting this study?
This is a collaborative study designed and implemented by the following organizations: Advocates for Youth, Black Women’s Health Imperative, Bold Futures, Ibis Reproductive Health, Indigenous Women Rising, and the National Latina Institute for Reproductive Justice.
How is this study being conducted?
Participants will answer questions in an online survey, which is available in English and Spanish. We estimate the survey will take 15 minutes to complete.
What should I do if I’m interested in participating?
Please click this link to see if you’re eligible to participate. Who can I contact if I have questions about the study?
Please reach out to the Opill Access Study team at opillaccess.ftp.ibis@gmail.com.